Micro-Technique Sampling

Status Completed

Clinical Trial Summary

This is a single-center, exploratory comparative pilot study to identify the most appropriate method for microbial consortia sampling from the skin.

Ten subjects are expected to complete the study at one investigative site in the United States.

The study will consist of 2 visits, Visit 1 (Screening), Visit 2 (Sampling). At Visit 1, subjects will be consented and have their eligibility reviewed. Visit 1 and Visit 2 may be combined into one visit. Visit 1 will involve the informed consent process, screening, and enrollment. Visit 2 will involve sampling of eight (8) test sites on the back with three (3) different sampling methods: swabbing (2 sites/method), cup scrub (2 sites/method), and tape stripping (4 sites/method). All samples will be returned to Kimberly Clark then sent to a laboratory for analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dermatitis

Clinical Trial Details

NCT number	NCT03242577
Study type	Observational
Source	Kimberly-Clark Corporation
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2017
Completion date	August 2, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Recruiting	`NCT01012453` - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema	N/A
Completed	`NCT00375713` - Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema	Phase 3
Completed	`NCT00001150` - Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers	N/A
Withdrawn	`NCT04154033` - Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone	Phase 2
Completed	`NCT05247333` - Implementation of a Minor Ailment Service in Community Pharmacy Practice	N/A
Completed	`NCT02979210` - Infant Fecal Insult Study	N/A
Completed	`NCT02615912` - A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants	N/A
Withdrawn	`NCT01125761` - Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis	Phase 3
Withdrawn	`NCT00746382` - A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)	Phase 2
Terminated	`NCT00176956` - Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients	Phase 3
Completed	`NCT05001139` - Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam	N/A
Completed	`NCT00801502` - Salmon in Pregnancy Study	N/A
Completed	`NCT00005781` - Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles	N/A
Completed	`NCT05324618` - Tacrolimus Versus Hydrocortisone in Atopic Dermatitis	Phase 4
Completed	`NCT04826471` - Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam	N/A
Recruiting	`NCT06436183` - A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis	Phase 2